Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

Kristen Kopp; Lukas Motloch; B. Wernly; Alexander E. Berezin; Victoria Maringgele; Anna Dieplinger; Uta C. Hoppe; Michael Lichtenauer

doi:10.3389/fphar.2024.1357334

Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

Kristen Kopp
, Lukas Motloch
, B. Wernly
, Alexander E. Berezin
, Victoria Maringgele
, Anna Dieplinger
, Uta C. Hoppe
, Michael Lichtenauer

Faculty of Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	1357334
Number of pages	1
Journal	Frontiers in Pharmacology
Volume	15
DOIs	https://doi.org/10.3389/fphar.2024.1357334
Publication status	Published - Jun 2024

Fields of science

303 Health Sciences
304 Medical Biotechnology
305 Other Human Medicine, Health Sciences
301 Medical-Theoretical Sciences, Pharmacy
302 Clinical Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3389/fphar.2024.1357334

Cite this

Kopp, K., Motloch, L., Wernly, B., Berezin, A. E., Maringgele, V., Dieplinger, A., Hoppe, U. C., & Lichtenauer, M. (2024). Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region. Frontiers in Pharmacology, 15, Article 1357334. https://doi.org/10.3389/fphar.2024.1357334

@article{c07b4a5b457b4256a3a61747d7d3ad95,

title = "Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region",

author = "Kristen Kopp and Lukas Motloch and B. Wernly and Berezin, \{Alexander E.\} and Victoria Maringgele and Anna Dieplinger and Hoppe, \{Uta C.\} and Michael Lichtenauer",

year = "2024",

month = jun,

doi = "10.3389/fphar.2024.1357334",

language = "English",

volume = "15",

journal = "Frontiers in Pharmacology",

issn = "1663-9812",

}

Kopp, K, Motloch, L, Wernly, B, Berezin, AE, Maringgele, V, Dieplinger, A, Hoppe, UC & Lichtenauer, M 2024, 'Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region', Frontiers in Pharmacology, vol. 15, 1357334. https://doi.org/10.3389/fphar.2024.1357334

TY - JOUR

T1 - Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

AU - Kopp, Kristen

AU - Motloch, Lukas

AU - Wernly, B.

AU - Berezin, Alexander E.

AU - Maringgele, Victoria

AU - Dieplinger, Anna

AU - Hoppe, Uta C.

AU - Lichtenauer, Michael

PY - 2024/6

Y1 - 2024/6

UR - https://www.scopus.com/pages/publications/85197461112

U2 - 10.3389/fphar.2024.1357334

DO - 10.3389/fphar.2024.1357334

M3 - Article

C2 - 38966548

SN - 1663-9812

VL - 15

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

M1 - 1357334

ER -

Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

Fields of science

UN SDGs

Access to Document

Other files and links

Cite this